Shenzhen Salubris Pharmaceuticals Co., Ltd.

This study tested a new injectable medicine called SAL003 in 720 adults with high cholesterol that wasn't controlled by statins alone. Participants received either SAL003 or a placebo alongside their usual statin therapy. The goal was to see if adding SAL003 could further lower '…

This study tested a new medicine called SAL003 in 618 adults with high cholesterol. Participants received either the drug or a placebo every 4 weeks for 12 weeks. The goal was to see if SAL003 could safely lower 'bad' LDL cholesterol more than placebo. After 12 weeks, all partici…

This study tested a new injectable medicine called SAL003, given together with a common statin pill (atorvastatin), in 214 adults with high cholesterol or mixed dyslipidemia. The goal was to see if the combination could safely lower 'bad' LDL cholesterol more than the statin alon…